2-Ethynylbenzaldehyde-Based, Lysine-Targeting Irreversible Covalent Inhibitors for Protein Kinases and Nonkinases-Reference-Cited by-同舟云学术

2-Ethynylbenzaldehyde-Based, Lysine-Targeting Irreversible Covalent Inhibitors for Protein Kinases and Nonkinases

Published:2023-02-12 Issue:7 Volume:145 Page:3844-3849
ISSN:0002-7863
Container-title:Journal of the American Chemical Society
language:en
Short-container-title:J. Am. Chem. Soc.

Author:

Chen Peng¹,Tang Guanghui²,Zhu Chengjun³,Sun Jie¹,Wang Xuan¹,Xiang Menghua¹,Huang Huisi³,Wang Wei¹²,Li Lin⁴^ORCID,Zhang Zhi-Min³,Gao Liqian¹^ORCID,Yao Shao Q.²^ORCID

Affiliation:

1. School of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University, Shenzhen 518107, China

2. Department of Chemistry, National University of Singapore, Singapore 117543, Singapore

3. School of Pharmacy, Jinan University, 601 Huangpu Avenue West, Guangzhou 510632, China

4. The Institute of Flexible Electronics (IFE, Future Technologies), Xiamen University, Xiamen 361005, China

Funder

National Research Foundation Singapore

National Natural Science Foundation of China

Publisher

American Chemical Society (ACS)

Subject

Colloid and Surface Chemistry,Biochemistry,General Chemistry,Catalysis

Link

https://pubs.acs.org/doi/pdf/10.1021/jacs.2c11595

Reference42 articles.

1. Recent advances in activity-based probes (ABPs) and affinity-based probes (AfBPs) for profiling of enzymes

2. Advances in covalent drug discovery

3. The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy

4. Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia

5. Discovery of a Potent and Selective EGFR Inhibitor (AZD9291) of Both Sensitizing and T790M Resistance Mutations That Spares the Wild Type Form of the Receptor

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structure‐Guided Drug Design Targeting Abl Kinase: How Structure and Regulation Can Assist in Designing New Drugs;ChemBioChem;2024-09-12

2. Rationally designed BCR-ABL kinase inhibitors for improved leukemia treatment via covalent and pro-/dual-drug targeting strategies;Journal of Advanced Research;2024-09

3. Aminomethyl Salicylaldehydes Lock onto a Surface Lysine by Forming an Extended Intramolecular Hydrogen Bond Network;Journal of the American Chemical Society;2024-08-23

4. Small Molecule-Induced Post-Translational Acetylation of Catalytic Lysine of Kinases in Mammalian Cells;Journal of the American Chemical Society;2024-08-20

5. Exploring the structural activity relationship of the Osimertinib: A covalent inhibitor of double mutant EGFRL858R/T790M tyrosine kinase for the treatment of Non-Small Cell Lung Cancer (NSCLC);Bioorganic & Medicinal Chemistry;2024-07